Ms. Chunyuan Wu (Brenda) has resigned from the board of directors and from her position as the chief financial officer (CFO) of LakeShore Biopharma Co. Ltd. (the Company), effective on June 14, 2024. Ms. Wu has advised the Company that her resignation was due to personal reasons and not a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company.

Following her resignation, the Board appointed Ms. Rachel Yu, a director of the Company, as the interim CFO while the Company searches for a permanent successor as CFO.